AGITATION,PSYCHOMOTOR
Clinical trials for AGITATION,PSYCHOMOTOR explained in plain language.
Never miss a new study
Get alerted when new AGITATION,PSYCHOMOTOR trials appear
Sign up with your email to follow new studies for AGITATION,PSYCHOMOTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Shock therapy for dementia agitation? new study tests ECT
Disease control Recruiting nowThis study tests whether adding electroconvulsive therapy (ECT) to usual care can safely reduce severe agitation in people with moderate to severe dementia, including Alzheimer's and other types. About 50 participants will receive ECT plus their regular care. The goal is to see i…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: NA • Sponsor: Brent Forester • Aim: Disease control
Last updated May 26, 2026 08:27 UTC
-
Could cannabis calm Alzheimer's agitation? new trial seeks answers
Symptom relief Recruiting nowThis study tests an oral medication called IGC-AD1, made from a cannabis compound (THC), to see if it safely reduces agitation in people with mild to severe Alzheimer's dementia. About 164 participants will take the drug or a placebo twice daily for several weeks. The goal is to …
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE2 • Sponsor: IGC Pharma, LLC • Aim: Symptom relief
Last updated May 26, 2026 08:29 UTC